Past Event

MIT Sloan Health Systems Initiative (HSI) Seminar with Delfi Krishna

USA
11:30AM - 1:00PM ET

When does investing in cell and gene therapy make good business sense?
Thursday April 13, 2023
11:30am - 1pm 
E62-450
Signup at Sloan Groups
In person lunch will be provided 

Join Zoom Meeting
Password: 100
One tap mobile
+16465588656,,93963234492
 
Meeting ID: 939 6323 4492

Cell and gene therapies represent an exciting and complex new treatment type, with the potential to treat a vast range of indications, in some cases offering the possibility of a disease cure with a single treatment. This presentation will discuss the multi-disciplinary business environment required to bring these cutting-edge medicines to patients.  
 
Delfi Krishna is currently the Vice President of Cell Therapy Portfolio Development at Immatics – a German biotech company with the mission to bring the power of T-cells to cancer patients.  She has a Ph.D in Chemical and Biomolecular Engineering from Georgia Tech and is currently an Executive MBA student at MIT Sloan. 

Delfi Krishna

Delfi Krishna

VP of Cell Therapy Portfolio Development at Immatics

Ph.D, Chemical and Biomolecular Engineering, Georgia Tech

Upcoming Events

to

MBA Program • Student Hosted Coffee Chats

Various Learn More

Paris Olympics Opening Ceremony

Cambridge, MA Learn More

The MBA Tour: New York City

New York City Learn More

Conexiones Virtual Grad School Fair

Online Learn More